EUTM file information

009997966

QWAD

May 25, 2011

Trademark Summary

The trademark application QWAD was filed by Gilead Sciences Ireland UC, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on June 27, 2011, and it was registered by office on October 4, 2011 without any oppositions.

The application was filed in English (French was selected as the second language).

The renewal of the trademark was recorded by the office on March 25, 2022.

of the trademark registration was recorded on March 25, 2022. Change of name and address of the trademark registration was recorded on January 22, 2014. A transfer of the trademark registration was recorded on October 7, 2014. Change of name and professional address of the trademark registration was recorded on April 23, 2015. Change of name and address of the trademark registration was recorded on May 22, 2016. Change of name and professional address of the trademark registration was recorded on January 31, 2019. Appointment and Replacement of representative of the trademark registration was recorded on December 1, 2019.

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical and veterinary preparations
    2. Pharmaceuticals for the treatment of HIV infection
    3. Antivirals
    4. Drugs for use in the treatment of infectious diseases.
  • The mark was filed in class 16 with following description of goods:
    1. Printed matter
    2. Manuals
    3. User guides
    4. Publications
    5. Flyers
    6. Pamphlets
    7. Brochures
    8. Stationery
    9. Reports
    10. Educational and informational materials in the field of pharmaceuticals, diseases and medical conditions and treatments
    11. Printed educational materials, namely brochures and posters concerning clinical trials and pharmaceuticals to treat HIV infection and AIDS-related diseases and disorders.
  • The mark was filed in class 44 with Information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including such services provided on-line from a computer network or the Internet and providing information and advisory services regarding HIV infection..